TY  - JOUR
T1  - Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: A population-based cohort study
AU  - Bajaj RR, Wald R, Hackam DG, et al
Y1  - 2012/04/09
N1  - 10.1001/archinternmed.2012.139
JO  - Archives of Internal Medicine
SP  - 594
EP  - 595
VL  - 172
IS  - 7
N2  - 
Routine use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) for the treatment of cardiovascular disease is well established.1- 2 However, because most randomized controlled trials have excluded patients with advanced chronic kidney disease,3 the role of ACEIs/ARBs in chronic dialysis patients remains poorly defined. Our objective was to determine whether ACEI/ARB use is associated with a reduction in mortality and major adverse cardiovascular events in older chronic dialysis patients.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2012.139
UR  - http://dx.doi.org/10.1001/archinternmed.2012.139
ER  -